Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E17K | ISIN: US6412558800 | Ticker-Symbol: NLZ0
München
10.05.24
08:03 Uhr
4,060 Euro
0,000
0,00 %
1-Jahres-Chart
NEUROMETRIX INC Chart 1 Jahr
5-Tage-Chart
NEUROMETRIX INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,0404,18022:59

Aktuelle News zur NEUROMETRIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.05.NeuroMetrix, Inc. - 8-K, Current Report1
19.04.NeuroMetrix names new independent director, terminates equity program; shares up2
19.04.NeuroMetrix, Inc. - 8-K, Current Report1
19.04.NeuroMetrix, Inc.: NeuroMetrix Announces Steps Taken to Enhance Shareholder Value334Joshua S. Horowitz joins Board of DirectorsAt-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced two steps to...
► Artikel lesen
05.04.NeuroMetrix, Inc. - 8-K, Current Report1
14.03.Study shows NeuroMetrix Inc's DPNCheck effective for DNP diagnosis2
14.03.NeuroMetrix, Inc.: NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy3
13.03.NeuroMetrix, Inc.: NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell Fibromyalgia151WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic...
► Artikel lesen
12.03.Echo Lake Capital urges Neurometrix to dismiss CEO1
12.03.Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired264NURO stock price has declined 99% since its IPOGozani has received compensation of over $10 million since the IPOGozani was charged by the FTC for various wrongdoings at NUROGozani apparently personally...
► Artikel lesen
08.03.RS Fund Management LLC: RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.489Stock trades significantly below its net cash per share.The board is arguably in breach of their fiduciary responsibility to protect shareholder value. Operating any capital raise at current price is...
► Artikel lesen
04.03.Echo Lake Capital urges Neurometrix to liquidate3
04.03.Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.241- Stock trades significantly below its net cash per share- Questions the Board's ability and/or desire to create shareholder value- Notes tremendous destruction of shareholder value under company's...
► Artikel lesen
01.03.NeuroMetrix, Inc. - 10-K, Annual Report2
23.02.Earnings call: NeuroMetrix reports Q4 revenue drop, shifts focus1
23.02.NeuroMetrix, Inc. (NURO) Q4 2023 Earnings Call Transcript1
22.02.NeuroMetrix, Inc. - 8-K, Current Report-
22.02.NeuroMetrix GAAP EPS of -$1.43, revenue of $1.32B1
22.02.NeuroMetrix, Inc.: NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights288WOBURN, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2023. The Company's...
► Artikel lesen
16.02.Fast Five: NeuroMetrix to review strategic options; FDA clears Merit Medical's surgical guidance system1
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2